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 Based on the structure of the most potential inhibitor diamidophosphate, 
various novel groups of inhibitors were developed by knowledge-based design 
approach with covalent carbon-phosphorus or carbon-phosphorus-carbon bond 
to improve hydrolytic stability to inhibit the microbial ureases. Designed 
compounds were evaluated with 10 (LigScore1, LigScore2, PLP1, PLP2, JAIN, 
PMF, PMF04, LUDI_1, LUDI_2 and LUDI_3) different scoring functions 
implemented in Discovery Studio and conformation analysis by AutoDock 
package. 
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1. INTRODUCTION 
Urease (urea amidohydrolase; E.C.3.5.1.5) is an enzyme that holds a salient place in the history of 
science (Figure 1). Urea was the first organic compound synthesized in laboratory [1], while urease derived 
from seeds of the Jack bean (JB) plant [2] is the first crystallized [3] and known as nickel containing enzyme 
[4].
 
It catalyzes urea hydrolysis in the nitrogen mineralization to form ammonia and carbamate, which later 
decomposes into ammonia and bicarbonate [5] [6]. First urease cleaved urea and produce one ammonia 
molecule and one of carbamate. Carbamate then decomposes in to ammonia and carbonic acid. Then, Carbonic 
acid equilibrates in water. As two molecules of ammonia become protonated to produce ammonium and 
hydroxide ions (Scheme 1). As a result there is a rise in the pH of the environment. Ammonia molecules thus 
formed are protonated by water at physiological pH, whereas the carbonic acid dissociates and cause an increase 
in pH [5] [6] [7] [8]. It involves environmental nitrogen transformations to provide nitrogen source to the 
organisms like algae, bacteria, fungi and plants [6].
 
But then, the reaction catalyzed by the dinuclear nickel 
active site of urease causes an aggregation of ammonia and a sharp pH increase, which has negative side effects 
in agriculture and health. For example, urease serves as a virulence factor in pathogens that are responsible for 
the development of diseases like kidney stones, pyelonephritis, and peptic ulcers [5] [6]. 
The precise information for the regions of the enzyme that is involved in the binding of inhibitors or 
substrates is the base in designing the efficient inhibitors which are capable to complement all the structural 
requirements for a close interaction. The urease active site (Figure 2) was found to contain pseudooctahedral, 
paramagnetic and bi-nuclear nickel ions in all the complexes of enzyme inhibitor analyzed so far [9] [10]. The 
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information of active site of urease was given through the resolved crystal structures for bacterial ureases from 
Klebsiella aerogenes [11] [12] and Bacillus pasteurii [9]. The active site was displayed to contain a binuclear 
nickel centre, in which the Ni-Ni distance was found 3.7Å in Bacillus pasteurii. In the center two nickel ions are 
bridged by a carbamylated lysine through its O-atoms, along Ni(1) further coordinated by two histidines with 
their N-atoms, and Ni(2) by two histidines also through N-atoms and furthermore by aspartic acid through its O-
atom.   
 
 
Figure 1. Ribbon diagram of the enzyme structure of bacillus pasteurii urease. The blue, light blue and 
light gray ribbons display α, β and γ subunits, respectively 
 
 
Figure 2. Schematic structure of the active site of urease
 [9]
 (Color scheme: carbon-grey; nitrogen-blue; 
oxygen-red; two nickel ions-yellow). Hydrogen bonds are shown as dashed lines. K=lysine.) 
 
Along with, the Ni ions are bridged by a hydroxide ion (WB), which along with two terminal water 
molecules, W1 on Ni(1), W2 on Ni(2), and W3 located near the opening of the active site, which forms an H-
bonded water tetrahedral cluster filling the active site cavity. It is the cluster (the carboxylate group of the 
carbamylated lysine and the hydroxide molecule) that urea replaces when binding to the active site for the 
reaction [11]. As a consequence of above ligations, Ni(1) is pentacoordinated and Ni(2) hexacoordinated, and 
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their coordination geometry is pseudo square pyramidal and pseudo octahedral, respectively. In another 
consideration, urease can severely decrease the efficiency of urea fertilizers to cause the release of large 
amounts of ammonia and further induce plant damage by ammonia toxicity and soil pH increase [11]. So, to 
control the rate of the enzymatic urea hydrolysis using urease inhibitors is an important goal. Large quantities of 
urea produced as a result of biological process. Each human being produces approximately 10 kg of urea per 
year. Spontaneous degradation of urea occurs with a half life of approximately 3.6 years [1], but in the presence 
of urease, the hydrolysis of urea is 104 times faster [7]. 
 
2. RESEARCH METHOD 
The crystal structure of Bacillus pasteurii urease in complex with inhibitor DAP
 
[13] retrieved from 
protein data bank
 
[14] (PDB Code: 3UBP) was used as the starting point.  To organize the active site of enzyme 
His137, His139, Ala170, Lys220, His222, His249, His275, Ala279, Gly280, Leu319, Cys322, His323, Ala366, 
Met367 and Asp363 amino acid residues and two Nickel ions (NI900,NI901) are selected [15] [16]. The 
structure of ligand (DAP) was appropriately modified by using Sketching module and fragment building tools in 
Discovery Studio 3.1 client program. In structure, missing bond orders, charges and angles were assigned and 
explicit hydrogens and hydrogen bonds were added. 
 
2.1 Molecular modeling 
From the created active site of enzyme, both Nickel ions and amino acids which are near and tightly 
bounded to them (His 137, His139, Lys220, His249, His275, Ala279 and Leu319) were applied to the fixed 
atom constraint tool of simulation [17] module of Discovery Studio 3.1 client program to limit the energy 
minimization. CHARMm [18] [19] force field was applied to the whole receptor-ligand complex. Apart from 
these, other part of active site was subjected to energy minimization using 1000 steps of „smart minimizer‟, with 
none of the implicit solvent model and with a dielectric constant of 1.0, Nonbonded List Radius was set to 14 
(nonbond higher cutoff distance 12, nonbond lower cutoff distance 10), With fixed minimization constraints and 
with Electrostatics spherical cutoff until either a RMS gradient of 0.1, or energy change and save result 
frequency of 0.0, was reached.  
 
2.2 Ligand Fit docking and scoring 
Ligand Fit, a modern docking program within Discovery Studio (Accelrys, San Diego, USA), was used 
for all runs. The Receptor-ligand complexes obtained after minimization were further used to determine the 
ligand binding affinity. The complex was splitted into the enzyme active site part and ligand part. By selecting 
only the active site part and using „Define and Edit binding site from current selection tool‟ of „Receptor-ligand 
interaction‟ module from the Discovery Studio 3.1 client, binding site sphere (of about 9.9 A°) was defined. 
After selecting both part (active site part and ligand part), docking studies were subjected to the „score ligand 
poses‟ module of Discovery Studio 3.1 client and 10 scoring functions (LigScore1 [20], LigScore2 [20], PLP1 
[21], PLP2 [21], JAIN [22], PMF [23], PMF04 [23], LUDI_1, LUDI_2, LUDI_3 [24] [25]) were implemented 
to evaluate the ligand binding affinity [26] [27] [28]. 
 
2.3 Molecular docking by AutoDock 
Software AutoDock [29] [30] including a graphical user interface, MGL Tools
 
[31] was utilized to 
generate grids, calculate dock score and assess the conformers. The structure of compounds were drawn using 
Discovery Studio client 3.1 and the energy minimization was implemented using CHARMm force field [18] 
[19] with smart minimize method to achieve a local minimum structure. These energy minimized structures are 
recognized for docking and the correlated pdbqt files were created in AutoDock. AutoDock needs the receptor 
and ligand coordinates in either Mol2 or PDB format. Other than the water molecules which are present in the 
active site (HOH 972, HOH 990, HOH 1043, HOH 1046, HOH 1167, HOH 1168 and HOH 1245), all other 
Nonpolar hydrogens were discarded from the receptor file (PDB
 
[32] code: 2UBP)
 
[9] and their partial charges 
were calculated to the parallel carbon atoms.  
The receptor file was converted into the pdbqt file format containing the receptor atom coordinates, 
partial charges and solvation parameters. The ligand file was reformed into a pdbqt file and torsions were 
determined. The grid calculations were implemented and maps were calculated with the use of AutoGrid [33] 
program. The grid maps were centered on the ligand binding site in the dimension of 120120120 points (x, y, 
z). The grid spacing was 0.375 Å and other AutoDock parameters were used default for docking. All docking 
runs were carried out using the Lamarckian genetic algorithm [34] and the achieved dock scores were noted in 
Kcal/mol. The docking protocol applied in analysis involved of 200 independent runs of each ligand, utilizing 
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an initial population of 250 randomly distributed individuals, a maximum number of 75 × 10
6
 energy 
evaluations, number of generation of 27 × 10
3
, a mutation rate of 0.02, a crossover rate of 0.8  [35]. 
 
3. RESULTS AND ANALYSIS 
Knowledge-based method is based on approved technique applied in the drug discovery, established as 
„scaffold-hopping‟ [36] [37] where the objective is to design a new structure starting from a known active 
compound through the modification of the central core of the molecule [38]. Generally, basic or initial structure 
and analogue based design studies are done using Glide, Gold, Ligand Fit or Catalyst to establish a comparative 
model, then fragment-based and knowledge-based approaches are applied to design molecules of selective 
inhibitors [39] [40] [41] [42]. 
 
 
 
 
Figure 3. Modeled structure of inhibitor C-36 to active site of Bacillus pasteurii urease. Hydrogen 
bonds are indicated as green lines. (Discovery Studio): the amino acid residue His222 of enzyme 
involved in hydrogen bond interaction with phosphinic acid group of inhibitor C-36 with a distance of 
1.5 Å. 
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H2N-CO-NH2 + H2O Urease NH3 + H2N-CO-OH
H2N-CO-OH + H2O NH3 + H2CO3
H2CO3 H
+ + HCO3
-
2NH3 + 2NH4
+ + 2OH-2H2O  
Scheme 1. Reaction of urease. 
 
 
 
Scheme 2. Chemical structure of DAP inhibitor of BPU.[43] 
 
 
 
 
 
 
C-44 C-43 C-42 
H
 
H
  
C-40 C-39 C-38 
 
 
 
 
C-36 C-35  
 
Scheme 3. Inhibitors constructed by using phenyl/aromatic/aliphatic rings with fluorine/chlorine 
substitution. 
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Table 1. Results of scoring functions of selected compounds and their binding energy with the enzyme. 
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C-44 1.5 4.45 9.47 -27.6 3.44 144.7 109.19 457 431 742 -2.95 
C-43 4.71 8.58 21.71 -9.21 7.6 65.7 29.96 586 543 651 -4.54 
C-42 2.63 6.6 10.12 1.48 2.84 91.94 27.9 377 353 394 -5.58 
C-40 1.04 2.28 -10.36 -25.86 7.34 108.82 63.99 540 501 745 -4.15 
C-39 6.72 14.13 74.93 -19.49 8.74 14.96 3.72 794 657 854 -3.66 
C-38 4.31 9.92 24.02 -7.95 8.53 132.92 51.38 476 466 606 -2.78 
C-36 5.01 10.12 36.82 -6.37 7.65 35.03 -11.66 411 426 635 -4.99 
C-35 2 5.08 -6.27 -21.48 3.87 123.48 76.25 459 431 529 -3.56 
 
 
BPU is an heteropolymeric molecule (αβγ)3 with exact threefold symmetry and contains flexible 
subunit composition which depends on organism. The structure of the active site of urease is highly conserved 
which contains two nickel ions and has a comparably small volume. Urease inhibitors which are distinct in 
structure have been effectively identified. The most efficient urease inhibitors are Diamidophosphate (DAP) 
(Scheme 2) and its derivatives, which hydrolyze to the active molecule (DAP) in the active site [43]. 
DAP is a transition state analogue. It loses stability in aqueous environments because it contains 
hydrolyzable (especially at low pH) P-N bonds in its structure [44]. So the effort was done to modify the 
structure of this transition state analogue by using highly stable P-C or C-P-C bonds to improve its activity and 
stability against Bacillus pasteurii urease. 
By using the knowledge-based design approach, 44 different compounds were designed to evaluate 
their potency against BPU. After designing the novel compounds using the knowledge of already synthesized 
urease inhibitors, they were energy minimized to the closest local minimum using the molecular mechanics 
CHARMm force field implemented in Discovery Studio. To study the interaction between the ligand and 
enzyme active site, all 44 compounds were docked in to the enzyme active site and were evaluated with 10 
different scoring functions (Ligscore 1, Ligscore 2, PLP1, PLP2, Jain, PMF, PMF04, Ludi-1, Ludi-2, Ludi-3) of 
Discovery Studio package. 
Automated docking was used to locate the appropriate binding orientations and conformations of 
different inhibitors in the BPU. To perform the task, genetic algorithm routine implemented in the program 
AutoDock was employed. Kollman charge, atomic solvation parameters and fragmental volumes were assigned 
to the protein using MGL Tools package. The program AutoGrid was used to generate the grid maps. 
Lamarckian genetic algorithm was applied for minimization using default parameters. The standard docking 
protocol was then applied by using AutoDock software package and binding free energies (Gb, Kcal/mol) were 
obtained. 
Inhibitor C-44, C-43, C-42, C-40, C-39, C-38, C-36 and C-35 (Table 1) (Scheme 3) are top ranked 
compounds according to evaluation of 10 scoring functions and binding free energy of AutoDock and these 8 
compounds have also obtained highest number of conformations which were quite well overlaid. The inhibitors 
constructed by using phenyl/aromatic/aliphatic rings with fluorine/chlorine substitutions were obtained top 
ranked compounds in most of the scoring functions among 44 different structures. 
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4. CONCLUSION 
By considering all scoring functions, inhibitor C-36 has achieved reliable scores values in all scoring 
functions (Figure 3). To sum up the attempt of designing organophosphorus compounds as Bacillus pasteurii 
urease inhibitors, many different compounds containing phosphate, phosphonate, phosphinate, phenyl/ 
cyclohexyl, pyrrole/cyclopentane in its structure were tested in silico based on knowledge of available inhibitors 
to improve its potency. From 8 of 10 scoring functions suggest that the compounds containing phenyl/ 
cyclohexyl/ pyrrole/ cyclopentane can be more potent structures as urease inhibitors than the compounds like 
phosphates/ phosphonates or phosphinates. 
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